The U.S. Food and Drug Administration (FDA) has approved the use of the drug Lenacapavir, marketed under the name Sonlinka, as an injectable treatment to suppress HIV, the causative agent of AIDS, in patients who have developed resistance to other drugs. What is Lenacapavir and how does it work? According to a report published by […]

Lenacapavir: How it works? yazısı ilk önce Bluesky Insider üzerinde ortaya çıktı.